These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21787829)

  • 1. MDCK cell line with inducible allele B NS1 expression propagates delNS1 influenza virus to high titres.
    van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ
    Vaccine; 2011 Sep; 29(40):6976-85. PubMed ID: 21787829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An A14U Substitution in the 3' Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs.
    Zheng M; Wang P; Song W; Lau SY; Liu S; Huang X; Mok BW; Liu YC; Chen Y; Yuen KY; Chen H
    J Virol; 2015 Oct; 89(20):10273-85. PubMed ID: 26223635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.
    Talon J; Salvatore M; O'Neill RE; Nakaya Y; Zheng H; Muster T; García-Sastre A; Palese P
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4309-14. PubMed ID: 10725408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetically engineered influenza A virus with ras-dependent oncolytic properties.
    Bergmann M; Romirer I; Sachet M; Fleischhacker R; García-Sastre A; Palese P; Wolff K; Pehamberger H; Jakesz R; Muster T
    Cancer Res; 2001 Nov; 61(22):8188-93. PubMed ID: 11719449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway.
    Hayman A; Comely S; Lackenby A; Murphy S; McCauley J; Goodbourn S; Barclay W
    Virology; 2006 Mar; 347(1):52-64. PubMed ID: 16378631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new panel of NS1 antibodies for easy detection and titration of influenza A virus.
    Tan Z; Akerstrom S; Wee BY; Lal SK; Mirazimi A; Tan YJ
    J Med Virol; 2010 Mar; 82(3):467-75. PubMed ID: 20087939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses.
    Ehrhardt C; Wolff T; Pleschka S; Planz O; Beermann W; Bode JG; Schmolke M; Ludwig S
    J Virol; 2007 Apr; 81(7):3058-67. PubMed ID: 17229704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine Virus.
    Chen C; Fan W; Li J; Zheng W; Zhang S; Yang L; Liu D; Liu W; Sun L
    Front Cell Infect Microbiol; 2018; 8():127. PubMed ID: 29765910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate.
    Wressnigg N; Voss D; Wolff T; Romanova J; Ruthsatz T; Mayerhofer I; Reiter M; Nakowitsch S; Humer J; Morokutti A; Muster T; Egorov A; Kittel C
    Vaccine; 2009 May; 27(21):2851-7. PubMed ID: 19366569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.
    Nicolodi C; Groiss F; Kiselev O; Wolschek M; Seipelt J; Muster T
    Vaccine; 2019 Jun; 37(28):3722-3729. PubMed ID: 31155415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the M-gene segment can substantially increase replication efficiency of NS1 deletion influenza A virus in MDCK cells.
    van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ
    J Virol; 2012 Nov; 86(22):12341-50. PubMed ID: 22951840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction and expression of eukaryotic expression vector of NS1 protein of influenza A (H1N1)].
    Zhang WS; Bian Q; Wen T; Chi Y; Li Y; Jiao YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):287-9. PubMed ID: 21419049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs.
    Solórzano A; Webby RJ; Lager KM; Janke BH; García-Sastre A; Richt JA
    J Virol; 2005 Jun; 79(12):7535-43. PubMed ID: 15919908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Conserved Residue, Tyrosine (Y) 84, in H5N1 Influenza A Virus NS1 Regulates IFN Signaling Responses to Enhance Viral Infection.
    Wang BX; Wei L; Kotra LP; Brown EG; Fish EN
    Viruses; 2017 May; 9(5):. PubMed ID: 28498306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes.
    Ferko B; Stasakova J; Romanova J; Kittel C; Sereinig S; Katinger H; Egorov A
    J Virol; 2004 Dec; 78(23):13037-45. PubMed ID: 15542655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus subpopulations: exchange of lethal H5N1 virus NS for H1N1 virus NS triggers de novo generation of defective-interfering particles and enhances interferon-inducing particle efficiency.
    Ngunjiri JM; Buchek GM; Mohni KN; Sekellick MJ; Marcus PI
    J Interferon Cytokine Res; 2013 Mar; 33(3):99-107. PubMed ID: 23215782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on virulence and pathogenicity of H5N1 influenza A virus through truncations of NS1 eIF4GI binding domain.
    Zhou H; Zhu J; Tu J; Zou W; Hu Y; Yu Z; Yin W; Li Y; Zhang A; Wu Y; Yu Z; Chen H; Jin M
    J Infect Dis; 2010 Nov; 202(9):1338-46. PubMed ID: 20854176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1.
    Mössler C; Groiss F; Wolzt M; Wolschek M; Seipelt J; Muster T
    Vaccine; 2013 Dec; 31(52):6194-200. PubMed ID: 24183981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens.
    Brahmakshatriya VR; Lupiani B; Reddy SM
    Vaccine; 2010 Mar; 28(12):2388-96. PubMed ID: 20064474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.